24-Year-Old Dies from Anaphylaxis After Caf Repeatedly Assured Him Food Was Peanut-Free

[Trigger Warning] Another tragic loss, this time of a young man simply trying to enjoy a vacation with his girlfriend. PLEASE heed the advice we provide at the end of the article.

New Treatment for EoE Shows Lasting Benefits in Major Clinical Trial

Exciting news on the treatment front: an established asthma therapy is yielding strong results when repurposed for eosinophilic esophagitis (EoE).

Novartis Launches Phase III Trial of Pill That Could Help Protect Against Reactions

A new Phase 3 trial from Novartis is testing whether an oral medication can protect against severe allergic reactions and anaphylaxis in just four weeks. Learn more about the study and see if you are eligible to enroll.

FDA Accepts Anaphylm Epinephrine Resubmission, Sets March 2027 Decision Date

Super exciting news Aquestive s sublingual emergency epinephrine candidate is on track for approval early next year. Fingers crossed!

Social Media Wellness Trend Linked to 1,180 Emergency Visits, Including Anaphylaxis

The "looksmaxxing" trend presents serious risks, particularly with the rise of injectable compounds. This report highlights the broader dangers associated with unregulated peptides worldwide.

Most Infants with Anaphylaxis Recover After One Epinephrine Dose According to Study

Helpful information for current and expecting parents of infants concerned about food allergies.